ARMYDA CRP - Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty C-reactive Protein
Project Objectives
To evaluate the prognostic significance of levels of inflammatory markers (C-reactive protein) and the platelet aggregation index by assessment of short- and long-term outcomes in patients undergoing percutaneous coronary revascularization.
Start/End Date
May 2012 - ongoing
Principal Investigators
- Dr.ssa Elisabetta Ricottini
- Dr. Giuseppe Patti
- Prof. Germano Di Sciascio
Host Institution
Campus Bio-Medico University of Rome